Laura Chico

Stock Analyst at Wedbush

(2.26)
# 2,647
Out of 4,893 analysts
227
Total ratings
37.25%
Success rate
-1.06%
Average return

Stocks Rated by Laura Chico

Maze Therapeutics
Jul 8, 2025
Initiates: Outperform
Price Target: $17
Current: $15.21
Upside: +11.77%
BioCryst Pharmaceuticals
Jun 30, 2025
Maintains: Outperform
Price Target: $16$18
Current: $8.94
Upside: +101.34%
Larimar Therapeutics
Jun 24, 2025
Maintains: Outperform
Price Target: $17$15
Current: $3.46
Upside: +333.53%
Lennar
Jun 18, 2025
Reiterates: Neutral
Price Target: $130
Current: $117.28
Upside: +10.85%
Biogen
Jun 12, 2025
Reiterates: Neutral
Price Target: $121
Current: $134.46
Upside: -10.01%
Pharvaris
Jun 5, 2025
Reiterates: Outperform
Price Target: $27
Current: $19.15
Upside: +41.03%
Vigil Neuroscience
May 22, 2025
Downgrades: Neutral
Price Target: $13$8
Current: $8.04
Upside: -0.44%
Travere Therapeutics
May 16, 2025
Reiterates: Outperform
Price Target: $30
Current: $16.40
Upside: +82.93%
Gossamer Bio
May 16, 2025
Reiterates: Outperform
Price Target: $4
Current: $1.35
Upside: +196.30%
Solid Biosciences
May 16, 2025
Maintains: Outperform
Price Target: $18$17
Current: $5.37
Upside: +216.57%
Reiterates: Outperform
Price Target: $17
Current: $10.39
Upside: +63.62%
Reiterates: Neutral
Price Target: $4
Current: $2.63
Upside: +52.09%
Maintains: Outperform
Price Target: $32$30
Current: $15.28
Upside: +96.34%
Maintains: Neutral
Price Target: $34$26
Current: $24.37
Upside: +6.69%
Maintains: Underperform
Price Target: $26$28
Current: $50.13
Upside: -44.15%
Maintains: Outperform
Price Target: $43
Current: $13.81
Upside: +211.37%
Maintains: Outperform
Price Target: $42$43
Current: $17.69
Upside: +143.14%
Maintains: Outperform
Price Target: $4$3
Current: $0.42
Upside: +613.44%
Reiterates: Outperform
Price Target: $36
Current: $20.76
Upside: +73.41%
Maintains: Outperform
Price Target: $27$28
Current: $6.75
Upside: +314.81%
Maintains: Neutral
Price Target: $30$29
Current: $19.40
Upside: +49.48%
Reiterates: Neutral
Price Target: $6
Current: $9.20
Upside: -34.78%
Maintains: Outperform
Price Target: $157$147
Current: $135.26
Upside: +8.68%
Reiterates: Neutral
Price Target: $46$48
Current: $30.82
Upside: +55.74%
Maintains: Outperform
Price Target: $19$12
Current: $1.26
Upside: +856.18%
Maintains: Outperform
Price Target: $50$49
Current: $33.03
Upside: +48.35%
Maintains: Neutral
Price Target: $8$7
Current: $3.56
Upside: +96.63%
Reiterates: Outperform
Price Target: $11
Current: $4.65
Upside: +136.81%
Reiterates: Outperform
Price Target: $42
Current: $17.12
Upside: +145.33%
Reiterates: Outperform
Price Target: $17
Current: $12.07
Upside: +40.85%
Maintains: Outperform
Price Target: $13$11
Current: $0.41
Upside: +2,566.02%
Reiterates: Neutral
Price Target: $5
Current: $3.99
Upside: +25.31%
Initiates: Market Perform
Price Target: n/a
Current: $58.92
Upside: -
Maintains: Outperform
Price Target: $9$5
Current: $2.55
Upside: +96.08%
Downgrades: Neutral
Price Target: $149
Current: $14.85
Upside: +900.00%
Initiates: Outperform
Price Target: $720
Current: $8.32
Upside: +8,557.28%
Initiates: Strong Buy
Price Target: $280
Current: $51.53
Upside: +443.37%